A familiar drug in unfamiliar territory: Will we manage to repurpose SGLT2 inhibitors in pulmonary arterial hypertension?

The Journal of Heart and Lung Transplantation · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles